samedan logo
 
 
 
spacer
home > pmps > summer 2020 > bearing obsolescence management
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Bearing Obsolescence Management

While the origin of the first bearing is unknown, Ancient Egyptian drawings depict tree trunks under sleds with liquid-lubricated runners used to move massive stone blocks. While not as old as Ancient Egyptian bearings, some bearings in use today may have been produced decades ago. So, what happens when manufacturers stop producing a certain type?

Pharmaceutical supply chains must be reliable and agile, now more than ever. Traditionally drug discovery and manufacturing has been a global effort, but the impact of COVID-19 has tested supply chain resilience. A recent report by GlobalData found that 95% of industry professionals were concerned about the impact of COVID-19 on company performance and 23% expressed concern about supply and demand.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Chris Johnson is Managing Director at Oxfordshire-based specialist bearing supplier, SMB Bearings. Having held this position for over 10 years, he is an expert in bearing, lubrication, and technical support services for a range of industries including chemical, pharmaceutical, food and beverage, marine, and robotics.
spacer
Chris Johnson at SMB Bearings
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Takeda Provides Updates on Its Pharmacokinetic-guided Prophylaxis Studies at ISTH 2020, Reinforcing Its Commitment to Advancing Personalized Care for People with Bleeding Disorders

July 12, 2020 - The Data Demonstrating Benefits of Pharmacokinetic-Guided Prophylaxis Therapy in Hemophilia and von Willebrand Disease are Among 13 Presentations from Takeda’s Hematology Portfolio and Pipeline
More info >>

White Papers

Risk-Based Inspection Readiness: Reducing Headaches with Advanced Preparation

The Avoca Group

So often, inspections are a major source of stress in the clinical trial environment. This is especially true when processes involved in preparing for an inspection are reactive. But, it doesn’t have to be that way. Using industry-leading practices and resources enables a proactive approach to mitigate—or even eliminate—the pain points associated with preparing for inspections.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement